Dr. Robert Kelly, MD
What this data tells you about Dr. Kelly
Dr. Robert Kelly is a geriatric medicine (internal medicine) physician in Fort Worth, TX, with 20 years in practice. Based on federal Medicare data, Dr. Kelly performed 4,324 Medicare services across 2,661 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kelly received a total of $812 from 10 pharmaceutical and/or device companies across 15 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in geriatric medicine (internal medicine) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kelly is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 666 | $87 | $250 |
| Office visit, established patient (20-29 min) | 354 | $63 | $200 |
| Blood draw (venipuncture) | 297 | $8 | $20 |
| Annual wellness visit, follow-up | 247 | $127 | $250 |
| Office visit, established patient, complex (40-54 min) | 242 | $123 | $300 |
| Office visit, established patient (10-19 min) | 240 | $39 | $150 |
| Insertion of needle into vein (3 years or older) | 220 | $12 | $40 |
| Telephone medical discussion with physician, 11-20 minutes | 218 | $63 | $125 |
| Telephone medical discussion with physician, 21-30 minutes | 212 | $97 | $155 |
| Electrocardiogram (EKG), 12-lead | 173 | $11 | $75 |
| Chronic care management, first 20 min/month | 101 | $44 | $100 |
| Drug injection, under skin or into muscle | 94 | $10 | $30 |
| Flu vaccine, high-dose | 93 | $72 | $85 |
| Flu vaccine administration | 87 | $29 | $30 |
| Telephone medical discussion with physician, 5-10 minutes | 86 | $40 | $75 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 86 | $29 | $100 |
| Nursing facility visit, low complexity | 82 | $54 | $125 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | 57 | $11 | $25 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | 55 | $140 | $175 |
| Remote evaluation of recorded video and/or images submitted by an established patient (e.g., store and forward), including interpretation with follow-up with the patient within 24 business hours, not originating from a related e/m service provided within t | 54 | $9 | $20 |
| Administration of vaccine | 49 | $13 | $30 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 47 | $184 | $325 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 45 | $17 | $100 |
| Nursing facility visit, moderate complexity | 42 | $81 | $150 |
| Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | 42 | $21 | $45 |
| Stool analysis for blood, by peroxidase activity | 41 | $4 | $20 |
| Exam of neurobehavioral status, first hour | 39 | $65 | $125 |
| Pneumococcal vaccine, 23-valent | 35 | $131 | $200 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 35 | $41 | $125 |
| Injection, ketorolac tromethamine, per 15 mg | 34 | $0 | $15 |
| Home visit, established patient, low complexity | 33 | $55 | $125 |
| Pneumonia vaccine administration | 30 | $30 | $33 |
| Annual alcohol misuse screening, 5 to 15 minutes | 29 | $18 | $25 |
| Advance care planning consultation, first 30 min | 28 | $65 | $125 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 27 | $3 | $10 |
| Home visit, established patient, moderate complexity | 21 | $92 | $175 |
| Transitional care management services for problem of high complexity | 21 | $217 | $350 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 20 | $25 | $75 |
| Test to measure expiratory airflow and volume | 17 | $19 | $50 |
| Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | 13 | $27 | $75 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 12 | $9 | $23 |
Industry Payment Transparency
Open Payments through 2023 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2023)
Associated products mentioned in payments ›
The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in geriatric medicine (internal medicine) physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kelly is a clinical cardiology specialist, with above-average Medicare volume (top 6% in TX), and speaking/promotional industry engagement, with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kelly experienced with office visit, established patient (30-39 min)?
Does Dr. Kelly receive payments from pharmaceutical companies?
How do Dr. Kelly's costs compare to other geriatric medicine (internal medicine) physicians in Fort Worth?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology